MedPath

KHERA MOHIT

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Hypoactive Sexual Desire Disorder in Males

Phase 2
Recruiting
Conditions
Low Libido
Interventions
Drug: Placebo
First Posted Date
2019-06-28
Last Posted Date
2025-02-14
Lead Sponsor
Mohit Khera
Target Recruit Count
60
Registration Number
NCT04002661
Locations
🇺🇸

Baylor College of Medicine, Houston, Texas, United States

Testosterone for Penile Rehabilitation After Radical Prostatectomy

Early Phase 1
Terminated
Conditions
Hypogonadism
Erectile Dysfunction
Interventions
Other: Placebo Testim®
First Posted Date
2009-02-20
Last Posted Date
2015-06-19
Lead Sponsor
Mohit Khera
Target Recruit Count
3
Registration Number
NCT00848497
Locations
🇺🇸

Baylor College of Medicine, Houston, Texas, United States

H-22411: BOTOX® for Peyronie's Disease

Phase 2
Completed
Conditions
Peyronie's Disease
Interventions
Other: Preservative free normal saline
Drug: 100 units of Botulinum Toxin Type A
Drug: 100 units Botulinum Toxin A
First Posted Date
2008-12-22
Last Posted Date
2024-04-08
Lead Sponsor
Mohit Khera
Target Recruit Count
12
Registration Number
NCT00812838
Locations
🇺🇸

Baylor College of Medicine, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath